Baseline characteristics of the study cohort
| Total, N=164 | ICH, n=60 | No ICH, n=104 | |
| Age (years) | 65 (56–75) | 67 (56–75) | 64 (55–75) |
| Female sex | 52 (31.7) | 22 (36.7) | 30 (28.8) |
| Comorbidities | |||
| Hypertension | 100 (61.0) | 34 (56.7) | 66 (63.5) |
| Diabetes mellitus | 69 (42.1) | 30 (50) | 39 (37.5) |
| Atrial fibrillation | 62 (37.8) | 32 (53.3) | 30 (28.8) |
| Current smoking | 71 (43.3) | 24 (40) | 47 (45.2) |
| Antiplatelet drug use | 20 (12.2) | 8 (13.3) | 12 (11.5) |
| Anticoagulant use | 12 (7.3) | 5 (8.3) | 7 (6.7) |
| Baseline laboratory values | |||
| Glucose, mg/dL | 6.9 (5.5–9.8) | 7.8 (6.1–10.2) | 6.6 (5.1–8.6) |
| Platelet count, ×109/L | 191 (158–232) | 186 (151–218) | 192 (164–234) |
| INR | 1.1 (0.9–1.3) | 1.1 (1.0–1.4) | 1.1 (0.9–1.3) |
| Stroke characteristics | |||
| Baseline NIHSS score | 13 (10–17) | 14 (12–18) | 12 (9–16) |
| Baseline GCS score | 13 (9–15) | 12 (9–14) | 13 (10–15) |
| ICA occlusion | 62 (37.8) | 20 (33.3) | 42 (40.4) |
| M1 occlusion | 96 (58.5) | 59 (98.3) | 37 (35.6) |
| M2 occlusion | 10 (6.1) | 4 (6.7) | 6 (5.8) |
| Left circulation | 84 (51.2) | 30 (50) | 54 (51.9) |
| Stroke treatment | |||
| Intravenous thrombolysis | 40 (24.4) | 15 (25) | 25 (24) |
| Onset-to-groin (min) | 327.5 (229.3–437.8) | 312.5 (237.5–421.5) | 332.5 (214.3–475.0) |
| Procedure time (min) | 119.5 (84–150) | 124 (92.3–174.5) | 116 (81.5–141.5) |
| General anesthesia | 18 (11.0) | 7 (11.7) | 11 (10.6) |
| Conscious sedation | 146 (89.0) | 53 (88.3) | 93 (89.4) |
| mTICI 0 | 15 (9.1) | 8 (13.3) | 7 (6.7) |
| mTICI 1 | 4 (2.4) | 2 (3.3) | 2 (1.9) |
| mTICI 2a | 26 (15.9) | 12 (20) | 14 (13.5) |
| mTICI 2b | 25 (15.2) | 7 (11.7) | 18 (17.3) |
| mTICI 3 | 94 (57.3) | 31 (51.7) | 63 (60.6) |
| Blood pressure variables, mm Hg | |||
| Admission SBP | 146±24.3 | 145±3.3 | 147±2.5 |
| Admission DBP | 80±13.7 | 81±1.8 | 79±1.4 |
| Admission MAP | 102.0 (92.7–109.6) | 102.3±2.0 | 101.4±1.5 |
| Outcomes | |||
| Any ICH | 60 (36.6) | ||
| HI-1 | 14 (8.5) | ||
| HI-2 | 17 (10.4) | ||
| PH-1 | 14 (8.5) | ||
| PH-2 | 15 (9.1) | ||
Variables are shown as mean±SD, n (%), or median and IQR.
DBP, diastolic blood pressure; GCS, Glasgow Coma Scale; HI, hemorrhagic infarction; ICA, internal carotid artery; ICH, intracerebral hemorrhage; INR, international normalized ratio; MAP, mean arterial pressure; mTICI, modified Thrombolysis in Cerebral Ischemia; NIHSS, National Institutes of Health Stroke Scale; PH, parenchymal hematoma; SBP, systolic blood pressure.